Death: Clinical Trials

6 trials for Death, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 unknown. 6 Phase 2, 2 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 26Unknown 6
Phase 12Unknown 2
Phase 31Unknown 1

Follow Death: new trials by email Literature Review of Death trials Research Report on Death

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effects of Dexmedetomidine in Patients With Agitated Delirium in Palliative Care
Dexmedetomidine Hydrochloride - Hyperactive Delirium, Delirium of Mixed Origin
Phase 1 / Phase 2UnknownBruyère Health Research Institute.502024-01-302025-04-15
Magnesium Sulphate Neuroprotective Strategies for Preterm Deliveries
Magnesium sulfate loading with maintenance dose, Magnesium sulfate loading dose only - Premature Birth, NEUROPROTECTION
Phase 2 / Phase 3UnknownZagazig University3362023-01-202023-07-14
Conscious Dying/Conscious Living: Ketamine-Assisted Psychotherapy
Ketamine Injectable Solution, Naturalistic Control - Illness Terminal
Phase 2UnknownThe Ketamine Research Foundation1202022-05-012022-02-25
The Response To Ajmaline Provocation in Healthy Subjects
Ajmaline - Brugada Syndrome, Sudden Death
Phase 2UnknownSt George's, University of London1002017-10-222019-11-05
Healthy Outcomes of Pregnancy Education
Cognitive Behavioral Therapy - Environmental Tobacco Smoke Exposure, Depression
Phase 2UnknownEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)17502001-07-012006-09-29
Comparing the Effect of Vaginal Misoprostol With Dinoprostone in Term Pregnancies
misoprostol, dinoprostone - Preeclampsia, Fetal Death
Phase 1 / Phase 2UnknownHormozgan University of Medical Sciences2007-06-01

Narrower conditions

Brugada Syndrome (1)  ·  Cerebral Palsy (1)  ·  Death, Sudden (1)  ·  Delirium (1)  ·  Depression (1)  ·  Fetal Death (1)  ·  Fetal Membranes, Premature Rupture (1)  ·  Infant Death (1)  ·  Perinatal Death (1)  ·  Pre-Eclampsia (1)  ·  Premature Birth (1)  ·  Psychomotor Agitation (1)  ·  Tobacco Smoking (1)

Broader conditions

Pathologic Processes (6)  ·  Pathological Conditions, Signs and Symptoms (6)  ·  Behavior (2)  ·  Behavioral Symptoms (2)  ·  Female Urogenital Diseases and Pregnancy Complications (2)  ·  Nervous System Diseases (2)  ·  Obstetric Labor Complications (2)  ·  Pregnancy Complications (2)  ·  Urogenital Diseases (2)  ·  Aberrant Motor Behavior in Dementia (1)  ·  Arrhythmias, Cardiac (1)  ·  Brain Damage, Chronic (1)  ·  Brain Diseases (1)  ·  Cardiac Conduction System Disease (1)

Interventions

Ajmaline (1)  ·  Cognitive Behavioral Therapy (1)  ·  Dexmedetomidine (1)  ·  Dinoprostone (1)  ·  Misoprostol (1)  ·  Prajmaline (1)  ·  Short-Wave Therapy (1)

Sponsors

Bruyère Health Research Institute. (1)  ·  Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (1)  ·  Hormozgan University of Medical Sciences (1)  ·  St George's, University of London (1)  ·  The Ketamine Research Foundation (1)  ·  Zagazig University (1)

Countries

Canada (1)  ·  Egypt (1)  ·  Iran (1)  ·  United Kingdom (1)  ·  United States (1)

Top investigators

Amro Alnemr, M.D. (1)  ·  Elijah Behr, MD (1)  ·  Hytham Atia, M.D. (1)  ·  James Downar, MDCM, MSc (1)  ·  Michele Kiely, DrPH (1)  ·  Minoo Rajaee Lari, Perinatologist - Obs and Gyn (1)  ·  Mitra Ahmad Soltani (1)  ·  Mohamed Arafa, M.D. (1)  ·  Mohamed Lashin, M.D. (1)  ·  Philip E Wolfson, MD (1)  ·  Sherief M El Gebaly, M.D. (1)

Results publications

PMID 19786427, PMID 20093899, PMID 20211945, PMID 21565525, PMID 21656058, PMID 21785892, PMID 27094910, PMID 32608505, PMID 39260823

NIH funding

2016 (1), U18HD030445 (1), U18HD030447 (1), U18HD031206 (1), U18HD031919 (1), U18HD036104 (1)